AI Meets Informed Consent: Opportunity, Risk, and What IRBs Need to See

The informed consent process is an ongoing dialogue that helps participants decide, with full understanding, whether to take part in a clinical trial. As generative AI begins to influence how consent documents are created, translated, and delivered, this process is becoming more complex.

Join experts in IRB oversight, research ethics, and health literacy to explore the opportunities and challenges of AI-assisted informed consent. This session will cover ethical foundations, emerging use cases for generative AI, and what sponsors and CROs need to communicate to IRBs when using these tools.

Designed for clinical operations leaders across biopharma, medtech, and CROs, this discussion will provide a practical framework for evaluating AI-driven consent approaches while keeping patient understanding and protection at the center.